Guardant Health
GH
#1121
Rank
โ‚น1.968 T
Marketcap
โ‚น14,553
Share price
-2.17%
Change (1 day)
67.54%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -โ‚น402.93

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น326.94. In 2022 the company made an earnings per share (EPS) of -โ‚น599.55 a decrease over its 2021 EPS that were of -โ‚น374.72.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น402.93-32.8%
2022-โ‚น599.5560%
2021-โ‚น374.7255.04%
2020-โ‚น241.69207.14%
2019-โ‚น78.69-19.81%
2018-โ‚น98.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น23.72-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น229.52-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA